Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis
- 31 January 2000
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (1) , 18-27
- https://doi.org/10.1053/rmed.1999.0708
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- In Vitro Activity of a New 8-Methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1998
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 1997
- Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tractThe American Journal of Medicine, 1995
- Epidemiology and Treatment of Chronic Bronchitis and Its ExacerbationsChest, 1995
- Antibiotics in Chronic Obstructive Pulmonary Disease ExacerbationsJAMA, 1995
- Epidemiology of Chronic Airways DiseaseChest, 1989
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987
- Quantitative sputum gram stains in chronic bronchial diseaseLung, 1979